Symposium
[Free Online Webcast] Regenerative Medicine: Latest Advances and Case Studies
Speakers:
Peter Santa Maria, MD, PhD, Professor, Stanford University; David Myung, MD, PhD, Professor, Stanford University; John Ramunas, PhD, CEO, Rejuvenation Technologies; Luis Alvarez, PhD, CEO, Theradaptive
Organizers:
Peter Staehr and Shichang Miao
Date:
2021-12-06
Time:
8:30-12:40 Pacific Time
Registration fee:
(USD):
Location:
Online via Zoom
Major Sponsor:
Vendor show vendors registered to date:
Registration: http://www.PBSS.org
Registration deadline:2021-12-05
(it will close sooner if the seating cap is reached)
About the Topic
Regenerative medicine includes the generation and use of therapeutic stem cells, tissue engineering, and the production of artificial organs. Regrowing, repairing, or replacing damaged or diseased cells, organs or tissues has the potential to tremendously benefit patients and our society as a whole. The mini-symposium intends to give the attendees some insight into these various areas of regenerative medicine.
The speakers will present on the translational development of the tympanic membrane to improve or enable hearing as well as the development of biomaterials for the cornea to improve the vision. What development techniques are available and what challenges must be overcome?
Another presentation provides insights on how to possibly treat fatal diseases of aging. When telomeres become too short, cells can't function, which is the major driver of disease and aging. Using mRNA encoding telomerase (TERT mRNA) has the potential to reverse telomere shortening.
The development of biomaterials for orthopedic applications is another important area in regenerative medicine. One approach is to deliver therapeutic proteins that enhance healing of implants. Coating the surface of implants with these proteins like paint can make them more readily available for cells of the body to interact with.
Tentative Agenda:
8:30 Am – 8:40 AM: Welcome and Introduction
8:40 AM – 9:30 AM: Engineering protein interfaces to create regenerative implants. Luis Alvarez, PhD, CEO, Theradaptive
9:30 AM – 10:20 AM: Regenerative biomaterials for the cornea. David Myung, MD, PhD, Professor, Stanford University
10:20 AM – 10:30 AM: Break
10:30 AM – 11:20 AM: Telomere extension using TERT mRNA. John Ramunas, PhD, CEO, Rejuvenation Technologies
11:20 AM – 12:10 PM: The translational journey of tympanic membrane regeneration. Peter Santa Maria, MD, PhD, Professor, Stanford University
12:10 PM – 12:40 PM: Panel Discussion
2024-04-26, [In-Person] Oncology Clinical Dose Optimization in Light of FDA Project Optimus
|
2024-05-06, [In-Person] Human Mass Balance and Metabolite Profiling Studies: Strategies, Technical Approaches, Regulatory Guidance, Applications and Case Studies
|
2024-05-13, [Free Online] Highlights of 2023 FDA Drug Approvals
|
2024-05-21, [In-Person] Nonclinical Safety Studies for IND and NDA Filing for Small Molecules: Nuts, Bolts and Best Practices
|
2024-05-30, [Free Online Workshop] Career Transition for Research Scientists: Career Overview, Project Management and Regulatory Affairs (jointly with BioPharmaPM and RAPS-SF)
|
2024-06-13, [In-Person] CMC Strategies and Activities for IND and NDA Filing for Small Molecules: Nuts, Bolts and Best Practices
|
2024-06-20, Alzheimer's Disease: untangling what we thought we knew and future Precision Medicine Diagnostics and Therapeutics
|
2024-07-24, [Free Online] The Science and Stories of Promising Biotech Startups: Symposium No.6
|
2024-09-10, [In-Person] Rethinking Translational PK/PD and Human Dose Projections for Novel Therapeutic Modalities: Covalent Inhibitors, PROTACs, Molecular Glues, ADCs, Ocular and Neuro delivery, Vaccines, Bispecifics, Cell and Gene Therapies
|
2024-09-20, [In-Person] Non-clinical safety assessments of biologics and novel modalities for IND/NDA Filing: Nuts, Bolts and Best Practices
|
2024-10-10, [In-Person] Regulatory Global Submission: Strategies and Best Practices for FDA, EMA and PMDA
|